PRAMEF3 Inhibitors
PRAMEF3 inhibitors are a class of chemical compounds designed to specifically target and inhibit the function of PRAMEF3, a member of the Preferentially Expressed Antigen in Melanoma Family (PRAME). PRAMEF3, like other members of the PRAME family, is believed to play a role in regulating gene expression by interacting with transcriptional machinery, potentially influencing cellular processes such as proliferation, differentiation, and apoptosis. While PRAMEF3 is not as extensively characterized as other PRAME family members, it is thought to be involved in modulating cellular responses to environmental cues and controlling the expression of specific gene sets related to growth and survival. By inhibiting PRAMEF3, researchers can disrupt these regulatory mechanisms, providing a tool to study the specific contributions of PRAMEF3 to transcriptional control and cellular dynamics.
In research, PRAMEF3 inhibitors are valuable for investigating the molecular mechanisms underlying gene regulation and the broader impact of transcriptional modulation on cellular function. By blocking PRAMEF3 activity, scientists can examine how its inhibition affects the transcription of genes under its regulatory influence, focusing on how this disruption alters cellular behavior, particularly in terms of growth, differentiation, and apoptosis. This inhibition enables the study of downstream effects on cellular pathways, including those involved in maintaining cellular identity and responding to stress or developmental signals. Additionally, PRAMEF3 inhibitors provide insight into how PRAMEF3 interacts with other members of the PRAME family or transcriptional co-regulators, shedding light on the complex regulatory networks that control gene expression. Through these studies, the use of PRAMEF3 inhibitors advances our understanding of transcriptional regulation, the role of PRAME proteins in cellular processes, and the broader implications of PRAMEF3 function in cellular homeostasis and adaptability.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This DNA methyltransferase inhibitor could hypothetically lead to the hypomethylation of the PRAMEF3 gene promoter, resulting in the silencing of its expression. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
As a cytosine analog, 5-Aza-2′-Deoxycytidine may incorporate into PRAMEF3 DNA during replication and decrease methylation, thus reducing expression of the PRAMEF3 gene. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
This histone deacetylase inhibitor may promote hyperacetylation around the PRAMEF3 gene locus, potentially resulting in chromatin remodeling that silences PRAMEF3 transcription. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
By inhibiting histone deacetylases, Panobinostat could hypothetically enhance histone acetylation near the PRAMEF3 gene, reducing its transcriptional activity. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $218.00 $634.00 | 1 | |
By altering the acetylation status of histones associated with the PRAMEF3 gene, Romidepsin may decrease PRAMEF3 gene transcription through chromatin condensation. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
This compound may intercalate into DNA at the PRAMEF3 gene, obstructing RNA polymerase advancement and thereby inhibiting PRAMEF3 mRNA synthesis. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Triptolide may interfere with transcription factor binding to the PRAMEF3 promoter region, leading to a decrease in PRAMEF3 gene expression. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
By binding to bromodomains, JQ1 could disrupt the chromatin structure at the PRAMEF3 locus, leading to a decrease in the expression of the PRAMEF3 gene. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Mithramycin A could specifically bind to G-C rich sequences of DNA within the PRAMEF3 promoter, preventing transcriptional initiation and thereby reducing PRAMEF3 expression. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
Disulfiram could inhibit the proteasomal degradation of transcriptional repressors, leading to their accumulation and subsequent repression of PRAMEF3 gene transcription. | ||||||